Literature DB >> 21285084

Elevated LH predicts ischaemic heart disease events in older men: the Health in Men Study.

Zoë Hyde1, Paul E Norman, Leon Flicker, Graeme J Hankey, Kieran A McCaul, Osvaldo P Almeida, S A Paul Chubb, Bu B Yeap.   

Abstract

CONTEXT: Hypogonadism in men is associated with insulin resistance, elevations in pro-inflammatory cytokines and fibrinogen, and an atherogenic lipid profile. However, it is uncertain whether the age-related decline in testosterone is associated with ischaemic heart disease (IHD) events.
OBJECTIVE: To determine whether testosterone and its associated hormones, sex hormone-binding globulin (SHBG) and LH, predict IHD events in older men.
DESIGN: Prospective cohort study.
METHODS: Between 2001 and 2004, 3637 community-dwelling men aged 70-88 years underwent a clinical assessment of cardiovascular risk factors and biochemical assessment of testosterone, SHBG and LH. Free testosterone was calculated using mass action equations. Participants were followed until December 2008 using electronic record linkage to capture IHD events (hospital admission or death).
RESULTS: Mean follow-up was 5.1 years. During this period, 618 men (17.0%; 95% confidence interval (CI) 15.8, 18.3%) experienced an event, of which 160 were fatal. Men with higher baseline total or free testosterone levels experienced fewer IHD events (hazard ratio (HR)=0.89; 95% CI 0.82, 0.97 and HR=0.86; 95% CI 0.79, 0.94 for each one s.d. increase in total and free testosterone respectively). These associations were maintained after adjustment for age and waist:hip ratio but did not persist after adjustment for prevalent IHD or other cardiovascular risk factors. SHBG was not associated with IHD events. In contrast, higher LH levels were associated with reduced event-free survival in both univariate (HR=1.15; 95% CI 1.08, 1.22) and adjusted analyses (HR=1.08; 95% CI 1.01, 1.15).
CONCLUSIONS: Dysregulation of the hypothalamic-pituitary-gonadal axis may be a risk factor for IHD. Further studies of men with either elevated LH or low testosterone are warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285084     DOI: 10.1530/EJE-10-1063

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  Seasonal variations of plasma gonadotropin, prolactin, and testosterone levels in primary and secondary hypogonadism: evidence for an independent testicular role.

Authors:  G Bellastella; E Pane; S Iorio; A De Bellis; A A Sinisi
Journal:  J Endocrinol Invest       Date:  2012-09-24       Impact factor: 4.256

Review 2.  Testosterone deficiency in male organ transplant recipients.

Authors:  Danly Omil-Lima; Erin Jesse; Karishma Gupta; Nicholas Sellke; Wade Muncey; Corey Burrelli; Ramy Abou Ghayda; Aram Loeb; Nannan Thirumavalavan
Journal:  Int J Impot Res       Date:  2022-01-11       Impact factor: 2.896

Review 3.  Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research Implications.

Authors:  Emily S Lau; Aleksandra Binek; Sarah J Parker; Svati H Shah; Markella V Zanni; Jennifer E Van Eyk; Jennifer E Ho
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 23.213

Review 4.  The role of hypogonadism in Klinefelter syndrome.

Authors:  Christian Høst; Anne Skakkebæk; Kristian A Groth; Anders Bojesen
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

Review 5.  Sex steroids and cardiovascular disease.

Authors:  Bu Beng Yeap
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

6.  Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study.

Authors:  Christian Høst; Lars C Gormsen; Britt Christensen; Niels Jessen; David M Hougaard; Jens S Christiansen; Steen B Pedersen; Michael D Jensen; Søren Nielsen; Claus H Gravholt
Journal:  Diabetes       Date:  2012-11-27       Impact factor: 9.461

Review 7.  Off-label use of hormones as an antiaging strategy: a review.

Authors:  Nikolaos Samaras; Maria-Aikaterini Papadopoulou; Dimitrios Samaras; Filippo Ongaro
Journal:  Clin Interv Aging       Date:  2014-07-23       Impact factor: 4.458

8.  Late-onset hypogonadism: beyond testosterone.

Authors:  Carlo Foresta; Aldo E Calogero; Francesco Lombardo; Andrea Lenzi; Alberto Ferlin
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

9.  High-fat diet disrupts metabolism in two generations of rats in a parent-of-origin specific manner.

Authors:  T J G Chambers; M D Morgan; A H Heger; R M Sharpe; A J Drake
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

Review 10.  Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men.

Authors:  Bu B Yeap
Journal:  Asian J Androl       Date:  2018 Mar-Apr       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.